藥碼
VAL02
藥名
Valganciclovir 錠劑 450 mg
英文商品名
Valcyte 錠劑 450 mg
中文商品名
克毒癒膜衣錠
螢幕名
Valcyte 錠劑 450 mg
劑型
Tab
規格
FC Tab 450 mg
成分
藥理分類
Necleoside & Nucleotide Antivirals
健保碼
BC24071100
ATC碼
藥品圖片
外觀圖片
適應症
#最小單位貼紙

抗病毒藥品 CMV retinitis; Prophylaxis of CMV disease
藥理
Valganciclovir is the valine ester prodrug that is hydrolyzed to ganciclovir after oral administration. It interferes with viral DNA synthesis and limits replication of all herpes viruses.
藥動學
Absorption:
1. Well absorbed; high-fat meal increases AUC by 30%
2. Bioavailability (With food): 60%
3. Time to peak: (Ganciclovir) 1.7 to 3 hours
Distribution:
1. Vdss: (Ganciclovir) 0.7 L/kg; widely to all tissue including CSF and ocular tissue
2. Protein binding: (Ganciclovir) 1% to 2%
Metabolism:
1. Converted to ganciclovir by intestinal mucosal cells and hepatocytes.
2. Half-life elimination (Ganciclovir, Mean range):
(1) 1 to <4 months: 3.5 hours; 4 months to 2 years: 2.8 to 4.5 hours; 2 to 12 years: 2.8 to 4.8 hours; 12 to 16 years: 4.4 to 6 hours
(2) Adults: 4.08 hours; prolonged with renal impairment
Excretion:
Urine (80% to 90%; primarily as ganciclovir)
禁忌症
1. Hypersensitivity to valganciclovir or ganciclovir
2. Absolute neutrophil count <500/mm3, platelet count <25,000/mm3 or Hgb<8 gm/dL
3. Patients on hemodialysis
懷孕分類
C; Fetal risk cannot be ruled out
哺乳分類
Avoided
副作用
Neutropenia (most common), thrombocytopenia, anemia, headache, insomnia, abdominal pain, diarrhea, nausea, vomiting
劑量和給藥方法
Cytomegalovirus (CMV) retinitis, treatment (AIDS-related):
1. Induction: 900 mg twice daily for 14 to 21 days followed by maintenance therapy
2. Maintenance: 900 mg once daily; may consider discontinuation in patients that have received 3 to 6 months of treatment, have inactive lesions, and CD4 count >100 cells/mm3 for 3 to 6 months in response to antiretroviral therapy
CMV, prophylaxis (solid organ transplant recipients):
900 mg once daily; duration of prophylaxis is dependent on type of transplant, as well as donor and recipient CMV serostatus
小兒調整劑量
腎功能調整劑量
Treatment dose:
1. CrCl ≥60 mL/min: usual dose (900 mg twice daily)
2. CrCl 40-59 mL/min: 450 mg twice daily
3. CrCl 25-39 mL/min: 450 mg once daily
4. CrCl 10-24 mL/min: 450 mg every 2 days
5. CrCl <10 mL/min: not recommended
Maintenance dose:
1. CrCl ≥60 mL/min: usual dose (900 mg once daily)
2. CrCl 40-59 mL/min: 450 mg once daily
3. CrCl 25-39 mL/min: 450 mg every 2 days
4. CrCl 10-24 mL/min: 450 mg twice weekly
5. CrCl <10 mL/min, hemodialysis: not recommended
肝功能調整劑量
安定性
藥袋資訊
臨床用途
巨細胞病毒視網膜炎、預防器官移植巨細胞病毒感染
主要副作用
腹瀉、噁心、嘔吐、腹部痛、頭痛、失眠等
泡製方法
儲存方式
請置於 15-30℃ 乾燥處儲存
注意事項
其他說明
藥局 W2 | 藥庫 口H21
藥品外觀
顏色
01
形狀
03
剝痕
標記1
VGC
標記2
450
其他
健保藥價
469
自費價
623.77
仿單
資料庫
健保給付規定